SCHEMBL4768263

SCHEMBL4768263

NN(O)Cc1ccc(-n2c3c(c4ccccc42)C(=O)CCC3)c(Br)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 4/20 0.45
HDAC6 Q9UBN7 4/20 0.45
KDM4E B2RXH2 3/20 0.35
TSHR P16473 2/20 0.35
ALDH1A1 P00352 2/20 0.35
CA1 P00915 3/20 0.34
CA2 P00918 3/20 0.34
TP53 P04637 1/20 0.34
CREBBP Q92793 1/20 0.34
HDAC10 Q969S8 1/20 0.32
MEN1 O00255 1/20 0.32
GLA P06280 1/20 0.32
CASP1 P29466 1/20 0.32
CASP7 P55210 1/20 0.32
KMT2A Q03164 1/20 0.32
HSD17B10 Q99714 1/20 0.32
PTGS1 P23219 1/20 0.32
PTGS2 P35354 1/20 0.32
HTR6 P50406 1/20 0.32
CSNK2B P67870 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5147102 0.80 HDAC1 (0.48) HDAC1HDAC6KDM4ETSHRALDH1A1
SCHEMBL5147159 0.79 HDAC1 (0.45) HDAC1HDAC6KDM4ETSHRALDH1A1
SCHEMBL4768253 0.78 HDAC1 (0.44) HDAC1HDAC6KDM4ETSHRALDH1A1
SCHEMBL5147071 0.78 HDAC1 (0.39) HDAC1HDAC6KDM4ECA1CA2
SCHEMBL4768273 0.76 HDAC1 (0.42) HDAC1HDAC6TP53CREBBPHDAC10
SCHEMBL5147104 0.75 HDAC1 (0.48) HDAC1HDAC6KDM4ETSHRALDH1A1
SCHEMBL4771960 0.69 CYP3A4 (0.43) HDAC1HDAC6KDM4EALDH1A1TP53
SCHEMBL4772324 0.69 HDAC1 (0.39) HDAC1HDAC6ALDH1A1TP53CREBBP
SCHEMBL5145477 0.69 HDAC1 (0.46) HDAC1HDAC6KDM4ETSHRALDH1A1
SCHEMBL5147126 0.69 HDAC1 (0.46) HDAC1HDAC6KDM4ETP53CREBBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1924557-A2 CARBAZOLE DERIVATIVES Serenex, Inc. (US) 2008-05-28 EP claimed
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US claimed
WO-2007035620-A2 CARBAZOLE DERIVATIVES SERENEX, INC. (US) 2007-03-29 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185184-A1 Carbazole derivatives CCNI, MKI67, CCNB3 HDAC1 145/4885HDAC6 204/4885KDM4E 2377/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.